A vaccine that combined the measles, mumps, rubella, and varicella antigens was licensed
On Sept. 6, 2005, the vaccine that combined the measles, mumps, rubella, and varicella antigens (Proquad by Merck)…
An inactivated, injectable influenza vaccine was licensed
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix) by GlaxoSmithKline (GSK) was licensed. The vaccine was…
FDA approved lowering the age limit to 12 mos for one of the two licensed hepatitis A vaccine
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
Sanofi Pasteur announced FDA approval of Menactra meningococcal conjugate vaccine indication for infants
On Apr. 22, 2005, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had granted licensure to…
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
CDC announced that rubella was no longer endemic in the U.S.
On Mar. 21, 2005, the U.S. Centers for Disease Control and Prevention (CDC) announced that a major public…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
The CDC assisted with the public health response to the devastating tsunami in the Indian Ocean
On Dec. 26, 2004, the U.S. Centers for Disease Control and Prevention (CDC) assisted with an earthquake measuring…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
A significant shortage of influenza vaccine occurred in the U.S.
On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…
Biotechnology | Chemical | Diagnostics | FDA | Infectious Disease | Life Science News | Radiology | Therapeutics | U.S. Congress
Project BioShield Act authorized FDA to expedite review procedures for treatments for chemical, biological and nuclear agents
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
An international call-to-action issued to conduct the annual observance of World Lupus Day
On May 10, 2004, an international call-to-action has been issued by more than one hundred lupus organizations based…
Tetanus and diphtheria toxoids adsorbed for adult use, preservative-free, was licensed
On Mar. 24, 2004, the U.S. Food and Drug Administration (FDA) licensed tetanus and diphtheria toxoids adsorbed for…
The National incident Management System was established to coordinate response for public health incidents
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
The Division of Global Migration and Quarantine controlled quarantine issues in the U.S.
In 2004, The Division of Global Migration and Quarantine, part of the CDC’s National Center for Infectious Diseases,…
Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Life Science History | Therapeutics | Vaccine
The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Michael Smith Genome Science Centre sequenced the SARS genome
On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…
Severe Acute Respiratory Syndrome (SARS) was placed on U.S. quarantine list
On Mar. 18, 2003, Severe Acute Respiratory Syndrome (SARS) was placed on U.S. quarantine list. Persons under quarantine…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | WHO
SARS (Severe Acute Respiratory Syndrome) was first discovered in Asia
On Mar. 6, 2003, the Singapore Ministry of Health (MOH) and the World Health Organization (WHO), announced they…
Severe Acute Respiratory Syndrome (SARS) was recognized
At t he end of February 2003, the World Health Organization (WHO) recognized Severe Acute Respiratory Syndrome (SARS)…
Public health officials were concerned about re-emergence of H5N1 avian influenza
In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…
The Institute for Collaborative Biotechnologies was founded
In 2003, The Institute for Collaborative Biotechnologies (ICB) was founded as an Army-sponsored University Affiliated Research Center (UARC)….
Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensed
On Dec. 13, 2002, the U.S. Food and Drug Administration (FDA) announced it had licensed a combined diphtheria…
President Bush announced a major smallpox vaccination program
On Dec. 13, 2002, President Bush announced a major smallpox vaccination program to protect the nation against the…
The Public Health Security and Bioterrorism Preparedness and Response Act (PL 107-188) was signed
On Sept. 10, 2002, the Public Health Security and Bioterrorism Preparedness and Response Act (P.L. 107-188) was passed…